Abstract

Remyelination of the peripheral and central nervous systems (PNS and CNS, respectively) is a prerequisite for functional recovery after lesion. However, this process is not always optimal and becomes inefficient in the course of multiple sclerosis. Here we show that, when acetylated, eukaryotic elongation factor 1A1 (eEF1A1) negatively regulates PNS and CNS remyelination. Acetylated eEF1A1 (Ac-eEF1A1) translocates into the nucleus of myelinating cells where it binds to Sox10, a key transcription factor for PNS and CNS myelination and remyelination, to drag Sox10 out of the nucleus. We show that the lysine acetyltransferase Tip60 acetylates eEF1A1, whereas the histone deacetylase HDAC2 deacetylates eEF1A1. Promoting eEF1A1 deacetylation maintains the activation of Sox10 target genes and increases PNS and CNS remyelination efficiency. Taken together, these data identify a major mechanism of Sox10 regulation, which appears promising for future translational studies on PNS and CNS remyelination.

The molecular mechanisms regulating remyelination are unclear. Here, the authors show that promoting deacetylation of eEF1A1 prevents the translocation of Sox10 outside the nucleus, contributing to maintaining the expression of Sox10 target genes and increasing remyelination efficiency.

Details

Title
EEF1A1 deacetylation enables transcriptional activation of remyelination
Author
Duman Mert 1   VIAFID ORCID Logo  ; Vaquié Adrien 2   VIAFID ORCID Logo  ; Nocera Gianluigi 1 ; Heller, Manfred 3 ; Stumpe, Michael 2 ; Devanarayanan, Siva Sankar 2 ; Dengjel Jörn 2   VIAFID ORCID Logo  ; Meijer Dies 4   VIAFID ORCID Logo  ; Yamaguchi Teppei 5   VIAFID ORCID Logo  ; Patrick, Matthias 5   VIAFID ORCID Logo  ; Zeis, Thomas 6 ; Schaeren-Wiemers Nicole 6   VIAFID ORCID Logo  ; Hayoz Antoinette 2 ; Ruff, Sophie 2 ; Jacob, Claire 1   VIAFID ORCID Logo 

 University of Fribourg, Department of Biology, Fribourg, Switzerland (GRID:grid.8534.a) (ISNI:0000 0004 0478 1713); Johannes Gutenberg University Mainz, Department of Biology, Mainz, Germany (GRID:grid.5802.f) (ISNI:0000 0001 1941 7111) 
 University of Fribourg, Department of Biology, Fribourg, Switzerland (GRID:grid.8534.a) (ISNI:0000 0004 0478 1713) 
 Proteomics and Mass Spectrometry Core Facility, Department for BioMedical Research, University of Bern, Bern, Switzerland (GRID:grid.5734.5) (ISNI:0000 0001 0726 5157) 
 Center for Discovery Brain Sciences, Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988) 
 FMI for Biomedical Research, Novartis Research Foundation, Basel, Switzerland (GRID:grid.482245.d) (ISNI:0000 0001 2110 3787) 
 University Hospital Basel, Department of Biomedicine, Basel, Switzerland (GRID:grid.410567.1) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2421630993
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.